139 related articles for article (PubMed ID: 22981363)
1. Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity.
Korprasertthaworn P; Rowland A; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Biochem Pharmacol; 2012 Dec; 84(11):1511-21. PubMed ID: 22981363
[TBL] [Abstract][Full Text] [Related]
2. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
3. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
Itäaho K; Laakkonen L; Finel M
Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
[TBL] [Abstract][Full Text] [Related]
4. Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8.
Fujiwara R; Nakajima M; Yamanaka H; Yokoi T
Drug Metab Dispos; 2009 Jan; 37(1):41-6. PubMed ID: 18832479
[TBL] [Abstract][Full Text] [Related]
5. Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4.
Kubota T; Lewis BC; Elliot DJ; Mackenzie PI; Miners JO
Mol Pharmacol; 2007 Oct; 72(4):1054-62. PubMed ID: 17636046
[TBL] [Abstract][Full Text] [Related]
6. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
[TBL] [Abstract][Full Text] [Related]
7. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
8. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
10. The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.
Patana AS; Kurkela M; Goldman A; Finel M
Mol Pharmacol; 2007 Sep; 72(3):604-11. PubMed ID: 17578897
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
[TBL] [Abstract][Full Text] [Related]
13. Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone.
Nishiyama T; Fujishima M; Masuda Y; Izawa T; Ohnuma T; Ogura K; Hiratsuka A
Arch Biochem Biophys; 2008 Oct; 478(1):75-80. PubMed ID: 18602884
[TBL] [Abstract][Full Text] [Related]
14. Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissues.
Oda S; Nakajima M; Hatakeyama M; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Aug; 40(8):1620-7. PubMed ID: 22619308
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
Kerdpin O; Knights KM; Elliot DJ; Miners JO
Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
17. Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4.
Bruck M; Li Q; Lamb JG; Tukey RH
Arch Biochem Biophys; 1997 Aug; 344(2):357-64. PubMed ID: 9264550
[TBL] [Abstract][Full Text] [Related]
18. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
[TBL] [Abstract][Full Text] [Related]
20. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]